FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38811611000001105: Olanzapine 5mg tablets (Bristol Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1535801000001110 Olanzapine 5mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1535821000001115 Olanzapine 5mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olanzapine 5mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olanzapine 5mg tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Has AMP True Olanzapine 5mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start